Rein Therapeutics, Inc. Adjustments to Additional Paid in Capital, Warrant Issued
Rein Therapeutics, Inc. (RNTX) reported Adjustments to Additional Paid in Capital, Warrant Issued of $741.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-15.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2024-04-15
- Rein Therapeutics, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2019-09-30 was $11.00K.
- Rein Therapeutics, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2023 was $741.00K.
- Rein Therapeutics, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2019 was $11.00K.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|
| 2023-12-31 | $741.00K 10-K · filed 2024-04-15 | |
| 2019-12-31 | $11.00K 10-K · filed 2021-03-24 | |
| 2019-09-30 | $11.00K 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |